ACTR-IC Polyclonal Antibody

ACVR1C is a type I receptor for the TGFB (see MIM 190180) family of signaling molecules. Upon ligand binding, type I receptors phosphorylate cytoplasmic SMAD transcription factors, which then translocate to the nucleus and interact directly with DNA or in complex with other transcription factors (Bondestam et al. 2001 [PubMed 12063393]).

The ACTR-IC Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of ACTR-IC protein in various biological samples. This antibody has been meticulously developed using advanced immunization techniques and exhibits exceptional sensitivity and specificity.

The ACTR-IC Polyclonal Antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a specific region of the ACTR-IC protein. The resulting antibody is purified using a combination of affinity chromatography and protein A/G purification methods, ensuring a high level of purity and minimal cross-reactivity.

This antibody has been extensively validated for its performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been shown to specifically recognize the ACTR-IC protein in a wide range of species, including human, mouse, and rat.

The ACTR-IC Polyclonal Antibody offers numerous advantages over other antibodies on the market. Its high specificity and sensitivity enable accurate and reliable detection of ACTR-IC protein, even at low expression levels. Additionally, its robust performance in different experimental techniques ensures versatility and flexibility in research applications.

Researchers and scientists can confidently rely on the ACTR-IC Polyclonal Antibody for their studies involving ACTR-IC protein. Its exceptional quality, reliability, and reproducibility make it an indispensable tool in the field of molecular biology and biomedical research.

Please note that this product is for research use only and is not intended for diagnostic or therapeutic purposes.